FDA approves Xdemvy for Demodex blepharitis
The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites.
Jul 31, 2023
0
1
The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites.
Jul 31, 2023
0
1
This winter, we're having to get our heads around another respiratory virus—RSV.
Jul 26, 2023
0
1
New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).
Jul 5, 2023
0
82
Scientists hope to learn more about the earliest stages of human development using models of embryos created from stem cells.
Jul 3, 2023
0
12
It's estimated celiac disease affects 1.4% of the world's population—a staggering 112,000,000 people or so in total.
May 16, 2023
0
1
An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment.
Mar 21, 2023
0
4
One in 10 new drugs were cleared by federal drug regulators in recent years based on studies that didn't achieve their main goals, a new study shows.
Feb 14, 2023
0
3
For generations people have associated the terms "lab rat" and "guinea pig" with scientific research. Animal testing remains a standard and has been required for drug approval.
Jan 16, 2023
0
55
Each year, many people look forward to ringing in the new year with family and friends. However, some celebrations include the combination of alcohol and late-night driving—which can lead to fatal accidents.
Dec 28, 2022
0
11
The Biden administration is again making some free COVID-19 tests available to all U.S. households as it unveils its contingency plans for potential coronavirus surges this winter.
Dec 15, 2022
0
11